Myers Robert Paul bought MIRM
October 9, 2026 · Form 4 insider transaction
Myers Robert Paul bought 40,000 shares of Mirum Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderMyers Robert Paul
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 9, 2026
Filing dateOctober 14, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/4th of the shares vest one year after September 21, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.